Trader consensus at 75.5% for a CDC Level 3 travel health notice by December 31 stems primarily from active global surveillance of respiratory and vector-borne outbreaks, including the recent hantavirus cluster on the MV Hondius cruise ship that prompted CDC emergency operations center activation at its lowest tier. Seasonal influenza circulation and confirmed chikungunya transmission in regions like Mauritius continue to elevate risks, aligning with historical patterns where the CDC issues “Reconsider Nonessential Travel” advisories when limited preventive measures exist and case thresholds are met. Official CDC and WHO monitoring data show ongoing case reporting that could cross geographic or intensity criteria before year-end, though model projections for variant emergence or spread remain uncertain and subject to rapid revision based on new laboratory confirmations.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트예
$117,078 거래량
$117,078 거래량
2026.12.31
예
$117,078 거래량
$117,078 거래량
2026.12.31
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus at 75.5% for a CDC Level 3 travel health notice by December 31 stems primarily from active global surveillance of respiratory and vector-borne outbreaks, including the recent hantavirus cluster on the MV Hondius cruise ship that prompted CDC emergency operations center activation at its lowest tier. Seasonal influenza circulation and confirmed chikungunya transmission in regions like Mauritius continue to elevate risks, aligning with historical patterns where the CDC issues “Reconsider Nonessential Travel” advisories when limited preventive measures exist and case thresholds are met. Official CDC and WHO monitoring data show ongoing case reporting that could cross geographic or intensity criteria before year-end, though model projections for variant emergence or spread remain uncertain and subject to rapid revision based on new laboratory confirmations.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
마켓 개설일: Jan 19, 2026, 3:15 PM ET
거래량
$117,078종료일
2026.12.31마켓 개설일
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus at 75.5% for a CDC Level 3 travel health notice by December 31 stems primarily from active global surveillance of respiratory and vector-borne outbreaks, including the recent hantavirus cluster on the MV Hondius cruise ship that prompted CDC emergency operations center activation at its lowest tier. Seasonal influenza circulation and confirmed chikungunya transmission in regions like Mauritius continue to elevate risks, aligning with historical patterns where the CDC issues “Reconsider Nonessential Travel” advisories when limited preventive measures exist and case thresholds are met. Official CDC and WHO monitoring data show ongoing case reporting that could cross geographic or intensity criteria before year-end, though model projections for variant emergence or spread remain uncertain and subject to rapid revision based on new laboratory confirmations.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
거래량
$117,078종료일
2026.12.31마켓 개설일
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus at 75.5% for a CDC Level 3 travel health notice by December 31 stems primarily from active global surveillance of respiratory and vector-borne outbreaks, including the recent hantavirus cluster on the MV Hondius cruise ship that prompted CDC emergency operations center activation at its lowest tier. Seasonal influenza circulation and confirmed chikungunya transmission in regions like Mauritius continue to elevate risks, aligning with historical patterns where the CDC issues “Reconsider Nonessential Travel” advisories when limited preventive measures exist and case thresholds are met. Official CDC and WHO monitoring data show ongoing case reporting that could cross geographic or intensity criteria before year-end, though model projections for variant emergence or spread remain uncertain and subject to rapid revision based on new laboratory confirmations.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트
외부 링크에 주의하세요.
외부 링크에 주의하세요.
자주 묻는 질문